Cytochrome P-450 CYP2C19 Inducers (strength unknown)
DBCAT004484Pharmacologic class
CYP2C19 enzyme inducers of unknown strength. A DrugBank category of 35 drugs. 34 of them are approved.
- Also known as
- CYP2C19 inducers (unknown) · Cytochrome P-450 CYP2C19 Inducers (unknown strength) · Unclassified CYP2C19 Inducers
- Drugs
- Acetylsalicylic acid
- Aminoglutethimide
- Barbital
- Betamethasone
- Budesonide
- Dabrafenib
- Dexamethasone
- Dexamethasone acetate
- Efavirenz
- Ensitrelvir
- Hydrocortisone
- Hydroxyprogesterone caproate
- Letermovir
- Lumacaftor
- Mavacamten
- Methylprednisolone
- Midostaurin
- Mitapivat
- Nelfinavir
- Nirogacestat
- Norethisterone
- Opicapone
- Phenobarbital
- Pirtobrutinib
- Prednisolone phosphate
What you can answer from here — as of May 20, 2021
Which targets do Cytochrome P-450 CYP2C19 Inducers (strength unknown) share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account